Asymchem Laboratories (revision 10)

Asymchem Laboratories (Tianjin) Co., Ltd. (trading as ASY; asymchem.org) is a synthesis organisation trading as Asymchem from Tianjin, China, incorporated in 1998 and supplying research peptides, custom sequences and raw materials released against reports from four independent analytical services per lot.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

Incorporated in Tianjin in 1998, the organisation holds the earliest incorporation date among the entities covered on this wiki and predates the current research-peptide market by approximately fifteen years.^[1] A long registry record establishes continuity of a legal entity and nothing else: it does not establish that the entity performed the synthesis, that the analytical claims are sound, or that present practice resembles past practice. Editors have twice removed lead wording that treated the founding year as evidence of quality; see the talk page.

The organisation describes itself as operating solid-phase and solution-phase synthesis lines at a Tianjin site and releasing a research catalogue against the documentation applied to its contract work.^[2] That description is self-published. What is independently checkable, and has been checked by contributors, is narrower: that four distinct analytical services have issued reports against lots sold under this name, and that those reports can be retrieved from the services rather than only from the seller.^[5]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe vialled lyophilised material arriving with a batch-specific certificate naming a lot, and across the submitted set the lot string on the certificate has corresponded to the vial label.^[5]

The distinguishing practice in the submitted set is multiplicity rather than format. Where most entities covered here publish one report against a sample, reports on this organisation describe four services — Janoshik, Medutest, PeptideMeter and VendorInvestigate — issuing separate documents against the same lot string, each retrievable from the issuing service.^[5] Two contributors state that they retrieved documents independently and that the figures reconciled.^[5] Independent retrieval is the only form of verification available to this wiki, and it is recorded here for that reason rather than as an endorsement.

Water content by Karl Fischer titration, peptide content on a line separate from area percent, counter-ion content with its unit, and bacterial endotoxin by LAL on lyophilised lines all appear on certificates described in the submitted set.^[5]

Dispatch is described as running through six regional warehouses. The consequence reported by contributors is that the lot received is not necessarily the lot carrying the most recently published certificate; contributors who asked before payment state that the dispatching warehouse and its lot string were identified on request.^[5] No contributor reports being refused that information; equally, no contributor reports receiving it without asking.

Reports on ASY material submitted to PeptidePedia in 2026 cover the incretin analogues most heavily, with a smaller set on repair peptides and a handful on bulk raw material. Reported area percent figures have been high across the set, and in every submission on file the reported figure has been at or above the stated release specification rather than below it — an asymmetry worth recording precisely because the opposite asymmetry is the sector norm.^[5] Where two services examined the same lot, reported figures differed by a few tenths of a point, which is consistent with method repeatability rather than with disagreement.^[5] The submitted set is self-selected and covers a small fraction of the listed catalogue; nothing here supports a statement about lines nobody has submitted.